Articles From: ARRIS To Present At 2014 UBS Global Technology Conference to Arrowhead to Present ARC-520 Phase 2a Data in Late-Breaking Session at AASLD Liver Meeting® 2014


SUWANEE, Ga.
Sign-up for ARRIS To Present At 2014 UBS Global Technology Conference investment picks
Arrow Electronics, Inc. (NYSE:ARW), today announced a distribution agreement with Rackspace ® (NYSE: RAX), a leading managed cloud company, that will expand the company’s cloud service portfolio in the United States and Canada.
Sign-up for Arrow Adds Rackspace to Cloud Services Portfolio investment picks
Arrow Electronics, Inc. (NYSE: ARW), today announced it is now an authorized North American Lenovo distributor System X and related solutions following the transition of IBM’s System X server business to Lenovo effective Oct.
Sign-up for Arrow Becomes Authorized Distributor of Lenovo Enterprise Products (Former IBM System X) investment picks
Arrow Electronics, Inc. (NYSE:ARW) announced today the approval by the company’s Board of Directors of the repurchase of up to an additional $200 million of common stock through a share repurchase program.
Sign-up for Arrow Electronics Announces Additional $200 Million Share Repurchase Program investment picks
Arrow Electronics Inc. (NYSE:ARW) today announced its Internet of Things Immersions Roadshow that will showcase how “Interconnected Intelligence” is changing the way the world interacts and solves problems with technology.
Sign-up for Arrow Electronics Internet of Things Immersions Tour to Showcase Future of “Interconnected Intelligence” investment picks
Arrow Electronics, Inc. (NYSE:ARW) today reported third-quarter 2014 net income of $146.9 million, or $1.47 per share on a diluted basis, compared with net income of $96.8 million, or $.95 per share on a diluted basis in the third quarter of 2013.
Sign-up for Arrow Electronics Reports Third-Quarter Non-GAAP Earnings Per Share of $1.40 investment picks
Arrow Electronics Inc. (NYSE:ARW) today announced the SAM Project was awarded a 2014 Institution of Engineering and Technology (IET) Award in the Intelligent Systems category during a recent ceremony in London.
Sign-up for Arrow Electronics SAM Project Wins 2014 Institution of Engineering and Technology Award investment picks
Arrow Electronics, Inc. (NYSE:ARW) announced that the company will host a conference call to discuss third-quarter 2014 financial results on October 29, 2014, at 1:00 PM ET.
Sign-up for Arrow Electronics to Host Third-Quarter 2014 Earnings Conference Call investment picks
Arrow Electronics, Inc. (NYSE: ARW), today announced that it now carries the complete RF and microwave portfolio from Analog Devices, Inc. (ADI), including the Hittite Microwave products.
Sign-up for Arrow Electronics to Offer Hittite Microwave Product Line investment picks
Arrow Electronics, Inc. (NYSE:ARW) announced that Paul J.
Sign-up for Arrow Electronics to Present at the UBS Global Technology Conference investment picks
2014/10/23
GLENS FALLS, N.Y. , Oct.
Sign-up for Arrow Financial Corporation Announces $5 Million Stock Repurchase Program investment picks
2014/10/22
GLENS FALLS, N.Y. , Oct.
Sign-up for Arrow Financial Corporation Declares Cash Dividend investment picks
2014/10/3
GLENS FALLS, N.Y. , Oct.
Sign-up for Arrow Named to Sandler O'Neill Sm-All-Star List for Financial Performance investment picks
Arrow Electronics, Inc. (NYSE: ARW) will carry Eurotech’s first cellular module in the Americas, ReliaCELL 10-20, making it the only distributor to offer this Eurotech product to date.
Sign-up for Arrow Offers Eurotech’s ReliaCELL 10-20 Module investment picks
2014/10/20
-- Third-quarter net interest income rose $1.2 million, or 8.7%, year over year.
Sign-up for Arrow Reports Third-Quarter Earnings Per Share Up 8.9%, Strong Asset Quality Ratios investment picks
Arrow Electronics, Inc. (NYSE:ARW) today announced it has added Hitachi Cloud Service for Content Archiving, delivered by Hitachi Data Systems (HDS), to Arrow’s cloud service portfolio and the ArrowSphere cloud marketplace in the United States.
Sign-up for Arrow to Add Hitachi Data Systems Cloud Storage to the ArrowSphere Cloud Services Marketplace investment picks
Arrow Electronics, Inc. (NYSE: ARW) today announced it has received the Global Sales Leadership Distributor award from Trend Micro, a global leader in security software and solutions.
Sign-up for Arrow Wins Trend Micro Global Sales Leadership Award investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it has appointed Patrick O’Brien as General Counsel.
Sign-up for Arrowhead Appoints Patrick O’Brien as General Counsel investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Susan Boynton has been appointed Vice President, Global Regulatory Affairs.
Sign-up for Arrowhead Expands Management Team with Appointment of Susan Boynton as Vice President Global Regulatory Affairs investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it recently filed an application for approval to begin a Phase 1 clinical trial of its RNAi-based therapeutic candidate, ARC-AAT, for the treatment of liver disease associated with alpha-1 antitrypsin deficiency.
Sign-up for Arrowhead Files for Regulatory Permission to Begin Phase 1 Trial of RNAi Therapeutic ARC-AAT investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today issued the following open letter to shareholders from President and CEO, Christopher Anzalone, Ph.D.: Dear Arrowhead Shareholders, Market reaction to our AASLD abstract took us by surprise because we have always believed that our public communications surrounding the ARC-520 Phase 2a study have been consistent and, more importantly, properly reflected the data we were seeing in the initial two cohorts.
Sign-up for Arrowhead Issues Open Letter to Shareholders investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that initial data from the ongoing Phase 2a study of ARC-520, its RNAi therapeutic candidate for the treatment of chronic hepatitis B (HBV) infection, was presented today in the late-breaking poster session at the 2014 American Association for the Study of Liver Diseases (AASLD) Liver Meeting in Boston.
Sign-up for Arrowhead Presents Data on ARC-520 and ARC-AAT at AASLD The Liver Meeting® 2014 investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced financial results for its fiscal 2014 fourth quarter and year ended September 30, 2014.
Sign-up for Arrowhead Reports Fiscal 2014 Year End Financial Results investment picks
2014/10/14
Former United States Securities and Exchange Commission attorney Willie Briscoe , founder of The Briscoe Law Firm, PLLC , and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed against Arrowhead Research Corporation (“Arrowhead” or “Company”) (NasdaqGS: ARWR) and several officers and directors for acts taken during the period of August 12, 2014 to October 8, 2014 (the “Class Period”). Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of Arrowhead.
Sign-up for Arrowhead Research Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors investment picks
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that data from the ongoing Phase 2a study of ARC-520, its RNAi therapeutic candidate for the treatment of chronic hepatitis B (HBV) infection, will be presented in the late-breaking poster session at the 2014 American Association for the Study of Liver Diseases (AASLD) Liver Meeting being held on November 7-11, 2014, in Boston.
Sign-up for Arrowhead to Present ARC-520 Phase 2a Data in Late-Breaking Session at AASLD Liver Meeting® 2014 investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: ARRIS To Present At 2014 UBS Global Technology Conference to Arrowhead to Present ARC-520 Phase 2a Data in Late-Breaking Session at AASLD Liver Meeting® 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent